CA2269656A1 - Peptide natriuretique cerebral (bnp) specifique pour un recepteur - Google Patents
Peptide natriuretique cerebral (bnp) specifique pour un recepteur Download PDFInfo
- Publication number
- CA2269656A1 CA2269656A1 CA002269656A CA2269656A CA2269656A1 CA 2269656 A1 CA2269656 A1 CA 2269656A1 CA 002269656 A CA002269656 A CA 002269656A CA 2269656 A CA2269656 A CA 2269656A CA 2269656 A1 CA2269656 A1 CA 2269656A1
- Authority
- CA
- Canada
- Prior art keywords
- arg
- ser
- gly
- seq
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73188096A | 1996-10-22 | 1996-10-22 | |
| US08/731,880 | 1996-10-22 | ||
| PCT/US1997/018384 WO1998017690A1 (fr) | 1996-10-22 | 1997-10-09 | Peptide natriuretique cerebral (bnp) specifique pour un recepteur |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2269656A1 true CA2269656A1 (fr) | 1998-04-30 |
Family
ID=24941306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002269656A Abandoned CA2269656A1 (fr) | 1996-10-22 | 1997-10-09 | Peptide natriuretique cerebral (bnp) specifique pour un recepteur |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0939770A1 (fr) |
| JP (1) | JP2001503256A (fr) |
| AU (1) | AU4816497A (fr) |
| CA (1) | CA2269656A1 (fr) |
| WO (1) | WO1998017690A1 (fr) |
| ZA (1) | ZA979060B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003297583B2 (en) | 2002-11-26 | 2010-01-14 | Biocon, Ltd | Modified naturetic compounds, conjugates, and uses thereof |
| PL3404102T3 (pl) | 2004-04-21 | 2021-12-13 | Alexion Pharmaceuticals, Inc. | Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość |
| CA2823066A1 (fr) | 2010-12-27 | 2012-07-05 | Alexion Pharma International Sarl | Compositions contenant des peptides natriuretiques et leurs methodes d'utilisation |
| US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
| RU2708068C2 (ru) | 2014-12-05 | 2019-12-04 | Алексион Фармасьютикалз, Инк. | Лечение судорог с использованием рекомбинантной щелочной фосфатазы |
| JP6868561B2 (ja) | 2015-01-28 | 2021-05-12 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | アルカリホスファターゼ欠損を有する被験者を治療する方法 |
| CN108350440A (zh) | 2015-08-17 | 2018-07-31 | 阿雷克森制药公司 | 碱性磷酸酯的制造 |
| EP3355904A4 (fr) | 2015-09-28 | 2019-06-12 | Alexion Pharmaceuticals, Inc. | Identification de régimes posologiques efficaces pour une thérapie de l'hypophosphatasie de remplacement de l'enzyme phosphatase alcaline non spécifique à des tissus (tnsalp) |
| WO2017074466A1 (fr) | 2015-10-30 | 2017-05-04 | Alexion Pharmaceuticals, Inc. | Méthodes de traitement de la craniosynostose chez un patient |
| US11065306B2 (en) | 2016-03-08 | 2021-07-20 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in children |
| US10898549B2 (en) | 2016-04-01 | 2021-01-26 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in adolescents and adults |
| EP3436052A4 (fr) | 2016-04-01 | 2019-10-09 | Alexion Pharmaceuticals, Inc. | Traitement d'une faiblesse musculaire à l'aide de phosphatases alcalines |
| WO2017214130A1 (fr) | 2016-06-06 | 2017-12-14 | Alexion Pharmaceuticals, Inc. | Impact du métal sur la production des phosphatases alcalines |
| JP7018933B2 (ja) | 2016-08-18 | 2022-02-14 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 気管気管支軟化症の治療方法 |
| US11224637B2 (en) | 2017-03-31 | 2022-01-18 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia (HPP) in adults and adolescents |
| WO2019190752A1 (fr) | 2018-03-30 | 2019-10-03 | Alexion Pharmaceuticals, Inc. | Production de glycoprotéines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995013296A1 (fr) * | 1993-11-12 | 1995-05-18 | Genentech, Inc. | Peptides natriuretiques auriculaires specifiques d'un recepteur |
-
1997
- 1997-10-09 ZA ZA979060A patent/ZA979060B/xx unknown
- 1997-10-09 CA CA002269656A patent/CA2269656A1/fr not_active Abandoned
- 1997-10-09 AU AU48164/97A patent/AU4816497A/en not_active Abandoned
- 1997-10-09 EP EP97910899A patent/EP0939770A1/fr not_active Withdrawn
- 1997-10-09 JP JP51943698A patent/JP2001503256A/ja not_active Ceased
- 1997-10-09 WO PCT/US1997/018384 patent/WO1998017690A1/fr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0939770A1 (fr) | 1999-09-08 |
| ZA979060B (en) | 1999-04-09 |
| AU4816497A (en) | 1998-05-15 |
| JP2001503256A (ja) | 2001-03-13 |
| WO1998017690A1 (fr) | 1998-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6028055A (en) | Receptor selective BNP | |
| US5846932A (en) | Receptor specific atrial natriuretic peptides | |
| US5665704A (en) | Receptor specific atrial natriuretic peptides | |
| EP0728147B1 (fr) | Peptides natriuretiques auriculaires specifiques d'un recepteur | |
| US6525022B1 (en) | Receptor specific atrial natriuretic peptides | |
| CA2269656A1 (fr) | Peptide natriuretique cerebral (bnp) specifique pour un recepteur | |
| US6025467A (en) | Parathyroid hormone derivatives and their use | |
| WO1994020534A1 (fr) | Peptide vasonatrine et analogues de ce dernier | |
| AU632043B2 (en) | Cyclic analogs of atrial natriuretic peptides | |
| US4607023A (en) | Natriuretic | |
| EP0543425B1 (fr) | ADN de l'endothéline et son utilisation | |
| JPH05255392A (ja) | Ａ−ｃ−ｂプロインスリン、その製造法および使用法、およびインスリン生産の中間体 | |
| EP1709065A2 (fr) | Processus d'echange de contre-ion pour peptides | |
| JPH0690780A (ja) | ヒト−レラキシン遺伝子 | |
| JP4166289B2 (ja) | 環式ｃｒｆアゴニスト | |
| EP0323740A2 (fr) | Analogues linéaires de peptides atrio-natriurétiques | |
| Sohma et al. | Comparative properties of insulin-like growth factor 1 (IGF-1) and [Gly7D-Ala] IGF-1 prepared by total chemical synthesis | |
| JPH0725799B2 (ja) | 高カルシウム体液性因子拮抗薬 | |
| AU8237187A (en) | Derivatives of atrial natriuretic peptides | |
| EP0315118A2 (fr) | ADN codant pour endothéline et son utilisant | |
| Morris et al. | Synthesis of mouse renin as a 2‐5‐33‐5 kilodalton pre‐pro‐two‐chain molecule and use of its cDNA to identify the human gene | |
| DK2209798T3 (en) | modified væksthormonpolypeptider | |
| JPH09157294A (ja) | 副甲状腺ホルモン誘導体 | |
| CA1340505C (fr) | Lactogene placentaire bovin | |
| US20170333530A1 (en) | Methods and materials for reducing cysts and kidney weight in mammals with polycystic kidney disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |